The subject of this disclosure pertains to boosting metabolism, assisting with weight loss, and improving cardiovascular health.
Prior metabolism boosters do not comprise the composition taught by this disclosure. Also, the metabolism boosters do not improve cardiovascular health.
The disclosure relates to compositions for boosting metabolic rate. It is well known that a high resting metabolic rate (RMR) can assist with weight control and weight loss.
The orally ingested compositions of this disclosure contain effective amounts of vitamins, minerals, herbs, fruit extracts, and other natural extracts and do not contain dangerous stimulants like Ephedrine, commonly known as Ma Huang. Other embodiments of the disclosure contain additional compounds which reduce or control levels of cholesterol and triglycerides or promote improved cardiovascular function.
Prior formulations for boosting metabolism fall short of the unique combinations of this disclosure. Unlike other metabolism-boosting formulations, the compositions disclosed herein include components which promote cardiovascular health, such as Vitamin D, coenzyme Q10, trans-resveratrol, red yeast rice and niacin.
The compositions described herein are unique combinations of specific vitamins, minerals, herbs, and nutraceutical compounds. A nutraceutical compound is a food or food product that reportedly provides health and medical benefits, including the prevention and treatment of disease. The essential components boost metabolic rate, help control appetite, and assist weight control and weight loss. Other components reduce or control the levels of total cholesterol, low density lipoproteins (LDL), and triglycerides, and may increase high density lipoproteins (HDL), as well. Other components are believed to promote improved cardiovascular function.
One composition contains Vitamin B12, chromium picolinate, trans-resveratrol, green tea extract, guarana, Vitamin D, DHEA or 7-keto DHEA, and coenzyme Q10.
In order to secure the desired result of boosting metabolic rate and assisting with weight control, the composition includes the following components:
In order to secure the desired result of promoting improved cardiovascular function or cardiovascular health, the composition includes the following components:
In addition to the key components, an inert filler, rice flour, is included in the composition.
In order to secure the desired result of further boosting metabolic rate, the following additional components may be provided:
Other embodiments of the compositions contain the additional nutraceutical compounds that help to control cholesterol or triglyceride levels. These nutraceutical compounds include:
Liquid—Solid Combination. In an embodiment, the compositions described herein, which contain only solid components, are packaged with other compositions that are contained in a liquid form. There are various nutraceutical and pharmaceutical compounds that cannot be chemically combined or physically mixed with each other due to factors such as instability of ingredients, insolubility, viscosity, incompatibility, taste, and reduced shelf life. For example, oil-based liquid products such as fish oil will not mix well with water-based liquids. However, it is often desirable to ingest these compounds at or close to the same time. Therefore, there is a need for a means of enabling a person to store or carry these chemically- or physically-incompatible compounds together so that they may be conveniently ingested together when so desired.
“Polyceutical” Combination. In an embodiment, the compositions described herein, which contain only nutraceutical components, are packaged with pharmaceutical compositions. The inventors have coined the term “Polyceutical” to name the combination of one or more nutraceutical compounds with one or more pharmaceutical compounds, i.e., defined as any chemical substance intended for use in the medical diagnosis, cure, treatment, or prevention of disease.
Examples of polyceuticals are: a combination of vitamin B6 and aspirin; a combination of vitamin B12 and aspirin; a combination of folic acid and aspirin; a combination of CoQ10 and ibuprofen; a combination of one of the nutraceutical compositions described in this disclosure and metformin (an oral antidiabetic drug in the biguanide class); and a combination of one of the nutraceutical compositions described in this disclosure and exenatide (a medication approved for the treatment of diabetes mellitus type 2 belonging to the group of incretin mimetics and administered as a subcutaneous injection).
A polyceutical combination is an effective means of providing two or more compounds that have complementary effects. For example, a polyceutical combination for assisting weight loss can combine a nutraceutical composition that boosts metabolism with a pharmaceutical compound that suppresses appetite, such as the FDA-approved prescription weight loss medication, phentermine. Another example, a polyceutical combination for improving cardiovascular health, can combine a nutraceutical composition that raises HDL (“good”) cholesterol with a statin medication, e.g., atorvastatin, which lowers LDL (“bad”) cholesterol.
The disclosure also includes a system and method for a metabolism boosting and cardiovascular wellness management program. This program may comprise the following steps:
This specification is to be construed as illustrative only and is for the purpose of teaching those skilled in the art the manner of carrying out the invention. It is to be understood that the forms of the invention herein shown and described are to be taken as the presently preferred embodiments. As already stated, various changes may be made in the shape, size and arrangement of components or adjustments made in the steps of the method without departing from the scope of this invention. For example, equivalent elements may be substituted for those illustrated and described herein and certain features of the invention maybe utilized independently of the use of other features, all as would be apparent to one skilled in the art after having the benefit of this description of the invention.
While specific embodiments have been illustrated and described, numerous modifications are possible without departing from the spirit of the invention, and the scope of protection is only limited by the scope of the accompanying claims.
This application claims priority from and incorporates herein by reference Provisional Application Ser. No. 61/460,870 entitled Compositions for Boosting Metabolism and Promoting Cardiovascular Health filed Jan. 10, 2011.
Number | Name | Date | Kind |
---|---|---|---|
6541522 | Inman et al. | Apr 2003 | B2 |
20020127285 | Xiu | Sep 2002 | A1 |
20050261257 | Vermeer | Nov 2005 | A1 |
20070010426 | Mao et al. | Jan 2007 | A1 |
20100272710 | Rebbaa | Oct 2010 | A1 |
20110033414 | Hennen | Feb 2011 | A1 |
20110092552 | Svensson et al. | Apr 2011 | A1 |
Number | Date | Country |
---|---|---|
WO 2006053184 | May 2006 | WO |
Number | Date | Country | |
---|---|---|---|
20120177623 A1 | Jul 2012 | US |
Number | Date | Country | |
---|---|---|---|
61460870 | Jan 2011 | US |